ArticleBMJ open2026

Efficacy and safety of intracoronary injection of recombinant human prourokinase in patients with slow blood flow/no-reflow during PCI for acute coronary syndrome: a randomised controlled, double-blind, placebo controlled, national multicentre clinical study protocol (PUK-ACS study).

Wenyu Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.